Logo

Harvard Bioscience, Inc.

HBIO

Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as well as a range of instruments and accessories for tis… read more

Healthcare

Medical Instruments & Supplies

24 years

USD

Exclusive to Premium users

Price

per share adjusted in USD

$0.65

Price

-2.78%

-$0.02

Market Cap

$28.970m

Small

Price/Earnings

-

Premium

3y Avg

Premium

5y Avg

Financial Reports

Key metrics over the past few years and other important metrics. Amounts in USD.

+5.6%

EBITDA Margin

-6.0%

Net Profit Margin

+3.0%

Free Cash Flow Margin

+5.6%

EBITDA Margin

-6.0%

Net Profit Margin

+3.0%

Free Cash Flow Margin
Revenue

$87.371m

-7.2%

1y CAGR

-8.1%

3y CAGR

-7.2%

5y CAGR
Earnings

-$53.835m

-334.0%

1y CAGR

-177.7%

3y CAGR

-934.3%

5y CAGR
EPS

-$1.22

-335.7%

1y CAGR

-173.5%

3y CAGR

-680.1%

5y CAGR
Book Value

$14.068m

$77.992m

Assets

$63.924m

Liabilities

$42.785m

Debt
Debt to Assets

54.9%

-1x

Debt to EBITDA
Free Cash Flow

$6.877m

+477.2%

1y CAGR

+1045.6%

3y CAGR

+677.3%

5y CAGR
No items found.
Press Releases
Statements and updates from the company
↑ TopSummaryPriceFinancialsPress Releases